MYRIAD GENETICS INC Annual Return On Equity in % from 2017 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Myriad Genetics Inc quarterly/annual Return On Equity history and growth rate from 2017 to 2022.
  • Myriad Genetics Inc Return On Equity for the quarter ending December 31, 2022 was -12.1 %, a 313% decline year-over-year.
  • Myriad Genetics Inc annual Return On Equity for 2022 was -12.1 %, a 313% decline from 2021.
  • Myriad Genetics Inc annual Return On Equity for 2021 was -2.93 %, a 87.9% increase from 2020.
  • Myriad Genetics Inc annual Return On Equity for 2020 was -24.3 %, a 5836% decline from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -12.1 -9.18 -313% Jan 1, 2022 Dec 31, 2022
2021 -2.93 +21.4 +87.9% Jan 1, 2021 Dec 31, 2021
2020 -24.3 -24.8 -5836% Jan 1, 2020 Dec 31, 2020
2019 0.42 -14.2 -97.1% Jul 1, 2018 Jun 30, 2019
2018 14.6 +12.2 +525% Jul 1, 2017 Jun 30, 2018
2017 2.33 Jul 1, 2016 Jun 30, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.